Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Aug;33(8):843-5.
doi: 10.1097/INF.0000000000000332.

Measles seropositivity in HIV-infected Kenyan children on antiretroviral therapy

Laura P Newman  1 , Anne Njoroge, Leila Ben-Youssef, Michele Merkel, Ann Gatuguta, Quy Ton, Elizabeth Maleche Obimbo, Dalton Wamalwa, Barbara Lohman-Payne, Barbra A Richardson, Ruth Nduati, Carey Farquhar
Affiliations

Measles seropositivity in HIV-infected Kenyan children on antiretroviral therapy

Laura P Newman et al. Pediatr Infect Dis J. 2014 Aug.

Abstract

This article describes results from a cross-sectional study among HIV-infected children 15 months to 12 years of age who were receiving antiretroviral therapy. We found a low prevalence of measles IgG seropositivity (45.7%) and identified CD4% ≥ 25 as a predictor. Most HIV-infected children on ART were not measles seropositive and might benefit from revaccination.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Comment in

References

    1. Nilsson A, Chiodi F. Measles outbreak in Africa--is there a link to the HIV-1 epidemic? PLoS pathogens. 2011;7(2):e1001241. Epub 2011/02/25. - PMC - PubMed
    1. Farquhar C, Wamalwa D, Selig S, et al. Immune responses to measles and tetanus vaccines among Kenyan human immunodeficiency virus type 1 (HIV-1)-infected children pre- and post-highly active antiretroviral therapy and revaccination. The Pediatric infectious disease journal. 2009;28(4):295–9. Epub 2009/03/05. - PMC - PubMed
    1. Chen RT, Markowitz LE, Albrecht P, et al. Measles antibody: reevaluation of protective titers. The Journal of infectious diseases. 1990;162(5):1036–42. Epub 1990/11/01. - PubMed
    1. WHO. Measles Vaccines: World Health Organization Position Paper. World Health Organization; 2009. pp. 349–60. [cited 84] Available from: http://www.who.int/wer/2009/wer8435/en/index.html.
    1. Viviani S, Mendy M, Jack AD, et al. EPI vaccines-induced antibody prevalence in 8–9 year-olds in The Gambia. Tropical medicine & international health: TM & IH. 2004;9(10):1044–9. Epub 2004/10/16. - PubMed

Publication types

MeSH terms